Back to HomeBeta

ICD-10 Coding for Malignant Tumor of Prostate(C61, C79.51, Z85.46)

Complete ICD-10-CM coding and documentation guide for Malignant Tumor of Prostate. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Prostate CancerAdenocarcinoma of Prostate

Related ICD-10 Code Ranges

Complete code families applicable to Malignant Tumor of Prostate

C61Primary Range

Malignant neoplasm of prostate

This is the primary code for diagnosing malignant neoplasm of the prostate.

Secondary malignant neoplasm of bone

Used when prostate cancer has metastasized to the bone.

Personal history of malignant neoplasm of prostate

Used for patients with a history of prostate cancer, no current treatment, and no evidence of disease.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C61Malignant neoplasm of prostateUse when there is active prostate cancer, confirmed by clinical tests.
  • PSA >4 ng/mL
  • Biopsy confirmed adenocarcinoma
  • MRI with PIRADS ≥4
C79.51Secondary malignant neoplasm of boneUse when prostate cancer has metastasized to the bone.
  • Bone scan showing metastasis
  • MRI confirming bone lesions
Z85.46Personal history of malignant neoplasm of prostateUse when the patient has a history of prostate cancer with no current treatment or evidence of disease.
  • No current treatment
  • No evidence of disease

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for malignant tumor of prostate

Essential facts and insights about Malignant Tumor of Prostate

The ICD-10 code for a malignant tumor of the prostate is C61, used for active cases.

Primary ICD-10-CM Codes for malignant tumor of prostate

Malignant neoplasm of prostate
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy confirms adenocarcinoma

documentation Criteria

  • Documented treatment plan or active surveillance

Applicable To

  • Adenocarcinoma of prostate

Excludes

  • Benign prostatic hyperplasia
  • Prostatitis

Clinical Validation Requirements

  • PSA >4 ng/mL
  • Biopsy confirmed adenocarcinoma
  • MRI with PIRADS ≥4

Code-Specific Risks

  • Incorrectly coding as historical when cancer is active.

Coding Notes

  • Ensure documentation specifies active treatment or monitoring.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for screening for malignant neoplasm of prostate

Z12.5
Use for routine screening encounters.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Carcinoma in situ of prostate

D07.5
Use D07.5 for in situ carcinoma, not invasive cancer.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Malignant Tumor of Prostate to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C61.

Impact

Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement.

Mitigation Strategy

Review imaging reports for metastasis., Include metastasis status in notes.

Impact

Reimbursement: Incorrect reimbursement for active treatment., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate patient records.

Mitigation Strategy

Verify current treatment status and PSA levels.

Impact

Risk of coding historical cancer as active.

Mitigation Strategy

Regularly review treatment status and PSA levels.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Malignant Tumor of Prostate, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Malignant Tumor of Prostate

Use these documentation templates to ensure complete and accurate documentation for Malignant Tumor of Prostate. These templates include all required elements for proper coding and billing.

Active Prostate Cancer Management

Specialty: Urology

Required Elements

  • PSA levels
  • Treatment plan
  • Metastasis status

Example Documentation

Patient with Gleason 7 adenocarcinoma, PSA 8.5 ng/mL, on leuprolide.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Prostate cancer stable.
Good Documentation Example
Gleason 3+4=7 adenocarcinoma, PSA 8.5 ng/mL, on leuprolide.
Explanation
The good example provides specific details on cancer status and treatment.

Need help with ICD-10 coding for Malignant Tumor of Prostate? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more